E

Epitomee Medical Ltd
TASE:EPIT

Watchlist Manager
Epitomee Medical Ltd
TASE:EPIT
Watchlist
Price: 979.8 ILS -3.56% Market Closed
Market Cap: 289.2m ILS
Have any thoughts about
Epitomee Medical Ltd?
Write Note

Intrinsic Value

The intrinsic value of one EPIT stock under the Base Case scenario is 268.91 ILS. Compared to the current market price of 979.8 ILS, Epitomee Medical Ltd is Overvalued by 73%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EPIT Intrinsic Value
268.91 ILS
Overvaluation 73%
Intrinsic Value
Price
E
Base Case Scenario

Valuation Backtest
Epitomee Medical Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for EPIT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about EPIT?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Epitomee Medical Ltd

Provide an overview of the primary business activities
of Epitomee Medical Ltd.

What unique competitive advantages
does Epitomee Medical Ltd hold over its rivals?

What risks and challenges
does Epitomee Medical Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Epitomee Medical Ltd.

Provide P/S
for Epitomee Medical Ltd.

Provide P/E
for Epitomee Medical Ltd.

Provide P/OCF
for Epitomee Medical Ltd.

Provide P/FCFE
for Epitomee Medical Ltd.

Provide P/B
for Epitomee Medical Ltd.

Provide EV/S
for Epitomee Medical Ltd.

Provide EV/GP
for Epitomee Medical Ltd.

Provide EV/EBITDA
for Epitomee Medical Ltd.

Provide EV/EBIT
for Epitomee Medical Ltd.

Provide EV/OCF
for Epitomee Medical Ltd.

Provide EV/FCFF
for Epitomee Medical Ltd.

Provide EV/IC
for Epitomee Medical Ltd.

Compare the intrinsic valuations
of Epitomee Medical Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Epitomee Medical Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Epitomee Medical Ltd compared to its peers.

Compare the P/E ratios
of Epitomee Medical Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Epitomee Medical Ltd with its peers.

Analyze the financial leverage
of Epitomee Medical Ltd compared to its main competitors.

Show all profitability ratios
for Epitomee Medical Ltd.

Provide ROE
for Epitomee Medical Ltd.

Provide ROA
for Epitomee Medical Ltd.

Provide ROIC
for Epitomee Medical Ltd.

Provide ROCE
for Epitomee Medical Ltd.

Provide Gross Margin
for Epitomee Medical Ltd.

Provide Operating Margin
for Epitomee Medical Ltd.

Provide Net Margin
for Epitomee Medical Ltd.

Provide FCF Margin
for Epitomee Medical Ltd.

Show all solvency ratios
for Epitomee Medical Ltd.

Provide D/E Ratio
for Epitomee Medical Ltd.

Provide D/A Ratio
for Epitomee Medical Ltd.

Provide Interest Coverage Ratio
for Epitomee Medical Ltd.

Provide Altman Z-Score Ratio
for Epitomee Medical Ltd.

Provide Quick Ratio
for Epitomee Medical Ltd.

Provide Current Ratio
for Epitomee Medical Ltd.

Provide Cash Ratio
for Epitomee Medical Ltd.

What is the historical Revenue growth
over the last 5 years for Epitomee Medical Ltd?

What is the historical Net Income growth
over the last 5 years for Epitomee Medical Ltd?

What is the current Free Cash Flow
of Epitomee Medical Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Epitomee Medical Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Epitomee Medical Ltd

Balance Sheet Decomposition
Epitomee Medical Ltd

Current Assets 29.5m
Cash & Short-Term Investments 29.4m
Receivables 178k
Non-Current Assets 5.8m
PP&E 5.5m
Other Non-Current Assets 270k
Current Liabilities 1.9m
Accounts Payable 1.3m
Other Current Liabilities 515k
Non-Current Liabilities 3.7m
Long-Term Debt 3.7m
Efficiency

Earnings Waterfall
Epitomee Medical Ltd

Revenue
10m USD
Operating Expenses
-16.9m USD
Operating Income
-6.9m USD
Other Expenses
912k USD
Net Income
-6m USD

Free Cash Flow Analysis
Epitomee Medical Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

EPIT Profitability Score
Profitability Due Diligence

Epitomee Medical Ltd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Negative ROE
Negative Operating Income
Negative Net Income
34/100
Profitability
Score

Epitomee Medical Ltd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

EPIT Solvency Score
Solvency Due Diligence

Epitomee Medical Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Epitomee Medical Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EPIT Price Targets Summary
Epitomee Medical Ltd

There are no price targets for EPIT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for EPIT?

Click here to dive deeper.

Dividends

Epitomee Medical Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for EPIT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Epitomee Medical Ltd

Country

Israel

Industry

Health Care

Market Cap

289.2m ILS

Dividend Yield

0%

Description

Epitomee Medical Ltd. develops and manufactures medical devices for obesity. The firm operates directly in the field of development, production and commercialization of medical platforms that are divided into two areas: the area of medical devices for weight loss and overweight, including the development and production of medical devices packed in capsules and ingested; the area of solutions for the introduction of drugs through ingestion that allows patients to take various medications that can be administered today only by injections. Both of the Company's solutions are intended for ingestion for patients for self-use, under a doctor's prescription and are under development.

Contact

CAESAREA
Tarshish 19
+972722505992
www.epitomeemedical.com

IPO

2021-12-15

Employees

38

Officers

Co-Founder & Chairman of the Board
Dr. Shimon Eckhouse Ph.D.
CEO & General Secretary
Dr. Radan Hashimshony Ph.D.
Vice President of Finance
Ms. Maya Gabrieli
Chief Operating Officer
Mr. Gal Aharonowitz
Vice President of Clinical Affairs
Dr. Yael Kidan
VP of Sales and Marketing
Mr. Alon Heth
Show More
Chief Medical & Regulatory Officer
Dr. Ruthie Amir M.D.
CEO of R&D
Dr. Argil Cohen
Show Less

See Also

Discover More
What is the Intrinsic Value of one EPIT stock?

The intrinsic value of one EPIT stock under the Base Case scenario is 268.91 ILS.

Is EPIT stock undervalued or overvalued?

Compared to the current market price of 979.8 ILS, Epitomee Medical Ltd is Overvalued by 73%.

Back to Top